Uniwersytecki Szpital Dzieciecy W Krakowie — Clinical Trial Site

41 Registered trials

20 Currently recruiting

Organisation

Uniwersytecki Szpital Dzieciecy W Krakowie

Location

Cracow, Poland

Identifier

ORG-100043358

Address

Ul. Wielicka 265, 30-663, Poland

Departments

#2401: Klinika Onkologii i Hematologii Dziecięcej
048006: Klinika Pediatii, Gastroenterologii i Zywienia
801:Oddzial Pediatrii, Reumatologii i Chorob Rzadkich
Clinic of Pediatric Oncology and Hematology
Department of Clinical Immunology
Department of Oncology and Hematology
Dept. Of Pediatric Oncology and Hematology
gastroenterology
Gastroenterology and Nutrition
Klinika Nefrologii Dziecięcej
Klinika onkologii i hematologii dziecięcej
Klinika Onkologii i Hematologii Dziecięcej Oddział Onkologii i Hematologii Dziecięcej
Klinika Pediatrii Gastroenterologii i Zywienia
Klinika Pediatrii, Gastroenterologii i Żywienia
Klinka Onkologii i Hematologii Dziecięcej, Instytut Pediatrii Wydział Lekarski Uniwersytetu Jagiello
Nephrology
Oddzial Onkologii I Hematologii Dzieciecej.Dept of pediatric oncology and hematology
Oddzial Pediatrii i Gastroenterologii
Oddział Nefrologii i Nadciśnienia Tętniczego / Stacja Dializ
Oddział Pediatrii i Gastroenterologii
Oddział Pediatrii i Gastroenterologii Klinika Pediatrii, Gastroenterologii i Żywienia UJ CM
Oddział Pediatrii, Reumatologii i Chorób Rzadkich
Oddział Transplantacji
Osrodek Transplantacji, Uniwersytecki Szpital Dzieciecy( #1)
Pediatric Oncology and Hematology Department
Szpital Dziecięcy, Klinika Nefrologii Dziecięcej

Clinical trials at this site (41)

Search interface

Immunotherapy with dinutuximab beta in combination with chemotherapy for the treatment of patients with primary neuroblastoma refractory to … Ended

2024-513141-37-00 Recurrent or progression of neuroblastoma or neuroblast 5 2024-05-06
A study to evaluate the efficacy and safety of treatment with JR-141 Ended

2024-512289-33-00 Mucopolysaccharidosis type II 5 2022-08-24
A Phase 3, Multicenter, Open-label, Basket, Long-term Extension Study of Ustekinumab in Pediatric Clinical Study Participants (2 to <18 Year… Ended

2022-501067-40-00 Moderately to Severely Active Ulcerative Colitis 5 2021-11-30
AIEOP-BFM 2017 POLAND - Collaborative treatment protocol for children and adolescents with acute lymphoblastic leukemia - A randomized phas… Ended

2024-517253-27-00 Acute lymphoblastic leukemia 5 2021-07-01
A global study of midostaurin in combination with chemotherapy to evaluate safety, efficacy, and pharmacokinetics in newly diagnosed pediatr… Ended

2023-509834-20-00 untreated FLT3-mutated Acute Myeloid Leukemia 4 2019-03-13
Research study to evaluate the experimental drug ferumoxytol, to see how well it works for children with chronic kidney disease (CKD) and ir… Ended

2024-516263-92-00 Iron Deficiency Anemia (IDA) in Pediatric Subjects with 5 2018-06-25
International trial in Philadelphia chromosome-positive acute lymphoblastic leukemia Ended

2024-515499-12-00 Acute lymphoblastic leukemia 5 2017-10-02
Evaluation of the efficacy of topical treatment with budesonide in children with Crohn's disease located in the esophagus and/or stomach and… Ended

2024-519269-23-00 Crohn's disease 5 2024-03-27
Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Oral Ozanimod in Pediatric Participants with Moderately to Severely Active Crohn… Ended

2023-508777-91-00 Moderately to Severely Active Crohn's Disease 10 2023-05-16
A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Ulcerative Colitis (UC) Ended

2023-509018-12-00 Moderately to severely active Ulcerative Colitis (UC) 5 2021-12-17
Prospective, open-label, single-arm, multicentre Phase 3 study to evaluate the pharmacokinetics, efficacy, tolerability, and safety of subcu… Ended

2024-511231-94-00 Human Normal Immunoglobulin 5 2021-10-27
A Phase 3 Study to Evaluate the Efficacy and Safety of Darvadstrocel in the Treatment of Complex Perianal Fistula in Pediatric Subjects with… Ended

2023-503973-39-00 Complex Perianal Fistulas in Crohn's Disease 5 2021-03-16
Clinical Study of the Efficacy, Safety and Pharmacokinetics of Ustekinumab as Intravenous Induction Treatment Followed by Subcutaneous Ustek… Ended

2023-504978-38-00 Moderately to Severely Active Crohn's Disease 5 2021-03-16
A Clinical Study of the Efficacy, Safety and Pharmacokinetics of Ustekinumab as Intravenous Induction Treatment Followed by Subcutaneous Ust… Ended

2023-504977-19-00 Moderately to Severely Active Ulcerative Colitis 5 2021-03-15
A Study of the Efficacy and Safety of Golimumab in Pediatric Participants with Moderately to Severely Active Ulcerative Colitis Ended

2023-507142-83-00 Ulcerative Colitis 5 2019-01-09
An extension study to investigate how safe Vedolizumab is in child patients with Ulcerative Colitis or Crohn's Disease Ended

2023-507766-35-00 Ulcerative Colitis or Crohn's Disease 4 2018-01-09
A Multi-Center, Open-Label Study of Adalimumab to Evaluate Long-Term Safety and Tolerability of Repeated Administration of Adalimumab in Ped… Ended

2023-504711-32-00 Ulcerative Colitis 5 2015-11-24